LC-MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-12. Anything still debated is marked as such rather than presented as settled.
Research on NAD+ often examines changes with age, diet, exercise, and disease states, but causal relationships are difficult to establish. Some studies measure NAD+ levels, while others assess enzyme activity or downstream markers. In the literature, terms such as "NAD+ decline" and "NAD+ boosting" appear in both scientific and commercial contexts, sometimes without precise definitions. Whether changes in measured NAD+ directly produce health effects remains an open question. Results from cells, animals, and humans cannot be assumed to translate directly.
Measuring NAD+ in biological samples requires rapid processing because the compound can degrade or interconvert after collection. Common approaches include enzymatic cycling assays, high-performance liquid chromatography, and mass spectrometry. Each method has different sensitivity, specificity, and susceptibility to interference from related nucleotides. Sample type matters: cultured cells, animal tissues, and human blood present distinct challenges. Reported values can vary widely across laboratories because of differences in extraction, normalization, and analytical platform. Standardization remains an open issue in the field.
In glycolysis, NAD+ accepts electrons during the oxidation of glyceraldehyde-3-phosphate, forming NADH. The tricarboxylic acid cycle and fatty acid oxidation also generate NADH, which donates electrons to the mitochondrial electron transport chain. This flow supports ATP synthesis and helps maintain the redox balance of the cell. Other dehydrogenases use NAD+ as a cofactor for biosynthetic reductions and detoxification reactions. NADH is later reoxidized to sustain continued flux through these pathways.
Beyond electron transfer, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer ADP-ribose units. Sirtuins, poly(ADP-ribose) polymerases, and CD38 consume NAD+ in regulatory reactions. These activities link NAD+ availability to DNA repair, chromatin modification, calcium signaling, and metabolic stress responses. Because consumption can exceed biosynthesis under some conditions, cellular NAD+ levels are dynamic rather than fixed. Enzyme affinity and local synthesis also influence how much NAD+ is available for signaling.
NAD+ is a dinucleotide composed of adenine, ribose, and nicotinamide moieties linked by phosphate groups. Its oxidized form carries a positive charge on the nicotinamide ring, which enables reversible hydride transfer. The molecule functions as a coenzyme in oxidoreductase reactions rather than as a dietary vitamin in its intact form. Cells maintain separate pools in cytoplasm, mitochondria, and nucleus. This compartmentalization allows distinct redox environments while preserving a shared chemical identity.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical solid form; varies with purity |
| Storage temperature | -20 °C or lower | Common for long-term dry storage |
| Solubility class | Water-soluble | Also dissolves in aqueous buffers |
| Typical analytical method | HPLC or LC-MS | Used for quantification in complex samples |
| UV absorbance maximum | About 259 nm | In neutral aqueous solution |
Measuring NAD+ in biological samples requires care because the molecule is chemically reactive and present at low concentrations in some tissues. Common approaches include enzymatic cycling assays, high-performance liquid chromatography, and liquid chromatography coupled to mass spectrometry. Each method has different sensitivity and specificity, and sample preparation can affect results. Acidic or alkaline extraction steps are used in some protocols, but the choice depends on the analyte and matrix. No single method is universally optimal for every tissue or fluid.
Solid NAD+ is relatively stable when kept dry, cold, and protected from light. Aqueous solutions are more vulnerable to hydrolysis and can lose activity during repeated freeze-thaw cycles or prolonged storage at ambient temperature. Stability depends on pH, ionic strength, and the presence of degrading enzymes or metal ions. For many laboratory uses, aliquots are stored frozen and thawed only once. Exact degradation rates vary by matrix, so stability should be checked for each application rather than assumed.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme built from two nucleotides joined by a phosphate linkage. One nucleotide carries adenine, and the other carries nicotinamide; the plus sign denotes a formal positive charge on the nicotinamide ring, not a free proton. In cells, NAD+ and its reduced partner NADH form a reversible redox pair. That pair participates in electron transfer reactions throughout metabolism. The abbreviation NAD+ is common in biochemistry, while NAD(H) sometimes denotes the combined pool.
The molecule was first described in the early twentieth century as a factor that promoted fermentation in yeast extracts. Later work linked it to hydrogen transfer and to the oxidation of nutrients in living tissues. Its structure was resolved as a dinucleotide, which explained why it could accept and donate electrons at specific enzyme sites. Today, NAD+ is recognized as a central substrate and signaling precursor, not merely a metabolic cofactor. Whether all observed NAD+ changes reflect causal signaling remains an open question.
Related compounds include NADH, the reduced form, and NADP+, which carries an additional phosphate group. NADP+ and NADPH often serve in biosynthetic and antioxidant reactions, while NAD+ and NADH are more associated with energy-yielding catabolism. Nicotinamide, nicotinic acid, and nicotinamide riboside are precursors that can enter salvage pathways. The exact contribution of dietary precursors to tissue NAD+ pools is an area of active investigation. Some studies measure labeled precursors to trace those routes.
NAD+ is a dinucleotide composed of two nucleotides joined by a pyrophosphate linkage. One nucleotide contains adenine, and the other contains nicotinamide. The oxidized form carries a positive charge on the nicotinamide ring and is abbreviated NAD+. It functions as a cofactor in hydride-transfer reactions, accepting electrons in catabolic pathways. In cells, it interconverts with reduced NADH, forming a redox couple central to energy metabolism. The molecule is water-soluble and does not cross cell membranes freely without specific transport or precursor pathways.
The nicotinamide ring undergoes reversible reduction at the para position, converting NAD+ to NADH. This reaction transfers a hydride equivalent, not a free hydrogen atom or electron alone. Because the redox pair has a defined reduction potential, it links oxidation of fuels to respiratory chain activity. Many dehydrogenases use NAD+ as a co-substrate and produce NADH. The ratio of NAD+ to NADH reflects metabolic state and influences flux through several pathways.
=== Laboratory synthesis === The chemical synthesis of psilocybin has been described. Albert Hofmann and colleagues first synthesized psilocybin in 1958. Since then, various chemists have improved the methods for laboratory synthesis and purification of psilocybin. In particular, Shirota and colleagues reported a novel method in 2003 for the synthesis of psilocybin at the gram scale from 4-hydroxyindole that does not require chromatographic purification. Fricke and colleagues described an enzymatic pathway for the synthesis of psilocybin and psilocin, publishing their results in 2017. Sherwood and colleagues significantly improved upon Shirota's method (producing at the kilogram scale while employing less expensive reagents), publishing their results in 2020.
tumefaciens without explanation to "B6", a strain now properly classified as Agrobacterium radiobacter (genomovar 4), causing misled researchers to propose the synonymization of the two. The original type strain of A. tumefaciens, reinstated in 2023, belongs to genomovar 1. Another strain of "A. tumefaciens" commonly used in early research was C58, which belongs to genomovar 8. For a review of the currently-known structure of the species complex, see Vargas Ribera et al. (2024), which also lists names that have been separately proposed for the genomovars. This article cites a great number of sources that do not distinguish among the genomovars. Most text in this article should be treated as describing the species complex as a whole.
Amodiaquine (ADQ) is a medication used to treat malaria, including Plasmodium falciparum malaria when uncomplicated. It is recommended to be given with artesunate to reduce the risk of resistance. Due to the risk of rare but serious side effects, it is not generally recommended to prevent malaria. Though, the World Health Organization (WHO) in 2013 recommended use for seasonal preventive in children at high risk in combination with sulfadoxine and pyrimethamine. Amodiaquine is a 4-aminoquinoline compound related to chloroquine. The side effects of amodiaquine are generally minor to moderate and are similar to those of chloroquine. Rarely liver problems or low blood cell levels may occur. When taken in excess headaches, trouble seeing, seizures, and cardiac arrest may occur. The WHO recommends its use for pregnant women during the second and third trimester as well as during lactation, but reports that evidence for use in the first trimester is still insufficient. Amodiaquine was first made in 1948. It is on the World Health Organization's List of Essential Medicines. While not available in the United States, it is widely available in Africa.
Lethal injection is the practice of injecting one or more drugs into a person (typically a barbiturate, paralytic, and potassium chloride) for the express purpose of causing death. The main application for this procedure is capital punishment. The drugs cause the person to become unconscious, stop breathing, and develop a heart arrhythmia, in that order. First developed in the United States, the method has become a legal means of execution in China, Thailand, Guatemala, Taiwan, the Maldives, Nigeria, and Vietnam, though Guatemala abolished the death penalty for civilian cases in 2017 and has not conducted an execution since 2000, and the Maldives has never carried out an execution since its independence. Although Taiwan permits lethal injection as an execution method, no executions have been carried out in this manner; the same is true for Nigeria. Lethal injection was also used in the Philippines until the country re-abolished the death penalty in 2006. Although primarily introduced as a more "humane" method of execution, lethal injection has been subject to criticism, being described by some as cruel and unusual. Opponents particularly critique the operation of lethal injections by untrained corrections officers and the lack of guarantee that the victim will be unconscious in every individual case. There have been instances in which condemned individuals were injected with paralytics and then with a cardiac arrest-inducing agent while still conscious; this technique has been compared to torture. Proponents often say that there is no reasonable or less cruel alternative.
Sources: en.wikipedia.org
=== The beginnings of the Rowett Research Institute === On 1 April 1914, Boyd Orr took charge of a new research institute in Aberdeen, a project of a joint committee for research into animal nutrition of the North of Scotland College of Agriculture and the University of Aberdeen. He had been offered the post on the recommendation of E. P. Cathcart, who had originally been offered the job, but had turned it down in favour of a chair in physiology in London. The joint committee had allocated a budget of £5,000 for capital expenditure and £1,500 for annual running costs. Boyd Orr recognised immediately that these sums were inadequate. Using his experience in his father's business of drawing up plans and estimating costs, he submitted a budget of £50,000 for capital expenditure and £5,000 for annual running costs. Meanwhile, with the £5,000 he had already been allocated he specified a building, not of wood as had been envisaged by the committee, but of granite and designed so that it could serve as a wing of his proposed £50,000 Institute. He accepted the lowest tender of £5,030, and told the contractors to begin work immediately. The committee were not pleased, but had to accept the fait accompli. When war broke out the contractors were told to finish the walls and roof, but to do no more for the time being.
The Wall Street Journal reported that several US Navy destroyers entered the Strait of Hormuz for the first time since the war began. A US official described the event as an "operation that focused on freedom of navigation through International waters”. Iranian government reportedly threatened to attack the ships, accusing US of ceasefire violation. US CENTCOM said the ships are taking part in mine clearance operations. JD Vance announced that the talks between the US and Iran had failed, as he was unable to reach an agreement after a day of negotiations. Afterwards, Trump declared a naval blockade on the Strait of Hormuz, announcing that the US Navy will prevent ships from entering or exiting the Strait and intercept vessels that have paid tolls to Iran. US CENTCOM announced that the blockade will be enforced on vessels of all nations entering or departing Iranian ports and coastal areas but "will not impede freedom of navigation for vessels transiting the Strait of Hormuz to and from non-Iranian ports." The IRGC Navy said that any military vessel approaching the strait would be considered a ceasefire violation and would meet a "severe response." On 21 April, US Senator Lindsey Graham praised the decision to leave the naval blockade in place, saying that it will be a source of pressure for the Iranian government. He also set out strict conditions for any potential agreement with Iran. On 12 May, ahead of his state visit to China, Trump was asked by a reporter about the extent to which he cared about Americans' financial situations while in negotiations with Iran.
The integumentary system consists of the covering of the body (the skin), including hair and nails as well as other functionally important structures such as the sweat glands and sebaceous glands. The skin provides containment, structure, and protection for other organs, and serves as a major sensory interface with the outside world.
Sources: en.wikipedia.org
== Health considerations == Normal functioning of the kidney, brain, liver, heart, and numerous other systems can be affected by uranium exposure because uranium is a toxic metal, although less toxic than other heavy metals, such as arsenic and mercury. It is weakly radioactive and is 'persistently' so because of its very long half-life. The Agency for Toxic Substances and Disease Registry states that: "to be exposed to radiation from uranium, you have to eat, drink, or breathe it, or get it on your skin." If DU particles do enter an individual, the type of danger presented—toxic vs. radiological—and the organ most likely to be affected depend on the solubility of the particles. In military conflicts involving DU munitions, the major concern is inhalation of DU particles in aerosols arising from the impacts of DU-enhanced projectiles with their targets. When depleted uranium munitions penetrate armor or burn, they create depleted uranium oxides in the form of dust that can be inhaled or contaminate wounds. The Institute of Nuclear Technology-Radiation Protection of Attiki, Greece, has noted that "the aerosol produced during impact and combustion of depleted uranium munitions can potentially contaminate wide areas around the impact sites or can be inhaled by civilians and military personnel". The use of DU in incendiary ammunition is controversial because of potential adverse health effects and its release into the environment. The U.S. Department of Defense claims that no human cancer of any type has been seen as a result of exposure to either natural or depleted uranium.
Sitagliptin (FDA approved in 2006, and marketed by Merck & Co. as Januvia) Vildagliptin (EU approved in 2007, and marketed in the EU by Novartis as Galvus) Saxagliptin (FDA approved in 2009, and marketed as Onglyza) Linagliptin (FDA approved in 2011, and marketed as Tradjenta by Eli Lilly and Company and Boehringer Ingelheim) Gemigliptin (approved in Korea in 2012, and marketed by LG Life Sciences as Zemiglo, among other names) Anagliptin (approved in Japan as Suiny in 2012; marketed by Sanwa Kagaku Kenkyusho Co., Ltd. and Kowa Company, Ltd.) Teneligliptin (approved in Japan as Tenelia in 2012) Alogliptin (FDA approved in 2013 as Nesina/Vipidia, and marketed by Takeda Pharmaceutical Company) Trelagliptin (approved for use in Japan as Zafatek/Wedica in 2015) Omarigliptin (MK-3102; approved as Marizev in Japan in 2015, having been developed by Merck & Co. In November 2015, Sheu and colleagues showed that omarigliptin could be used once-weekly and was generally well tolerated throughout the base and extension studies) Evogliptin (approved as Suganon/Evodine for use in South Korea) Gosogliptin (approved as Saterex for use in Russia) Dutogliptin (PHX- 1149; free base being developed by Phenomix Corporation. In a phase III trial as of April 2010) Neogliptin Retagliptin (SP-2086; approved in China) Denagliptin Cofrogliptin (HSK- 7653; compound 2) Fotagliptin Prusogliptin Cetagliptin (CGT 8012) Berberine, an alkaloid found in plants of the genus Berberis (the "barberry"), inhibits DPP-4, which may at least partly explains the chemical's antihyperglycemic activity.
The investigation had found out that in the period of 2004-2009, Gobozov was giving secret information on the deployment the military units of the Russian Ministry of Defence and the Border Service of the FSB on the South Ossetian territory to the secret services of Georgia. However, according to the agreement between Russia and Georgia, only the presence of the Russian contingent of the Joint Peacekeeping Forces was allowed in South Ossetia and their number, staff composition, equipment, places of deployment and every movement should have been known to Tbilisi. Thus, the Prosecutor General's Office of the Russian Federation admitted that non-peacekeeping Russian troops were present on the South Ossetian territory (which Russia then considered as the Georgian territory) without Tbilisi's consent before the war in August 2008. Russian journalist Yulia Latynina commented that by acknowledging the presence of the Russian troops on the de jure Georgian territory from 2004 to 2008, the Prosecutor General's Office of Russia admitted the crime of aggression of Russia. In 2012, Anatoly Khrulyov, the commander of the 58th Army, said in an interview that "For me, the war began in my workplace." He said that the decision to reinforce the Russian peacekeeping force was made on 5 August 2008. Khrulyov said that Marat Kulakhmetov, commander of the Joint Peacekeeping Forces called him on the night of 7–8 August and said that General Mamuka Kurashvili had warned him that Georgia was going to launch a large-scale military operation.
Sources: en.wikipedia.org
Researchers often use enzymatic cycling assays, liquid chromatography, or mass spectrometry. The choice depends on sample size, sensitivity needs, and available equipment. Because NAD+ can degrade quickly, rapid extraction and careful handling are important.
Differences can arise from sample type, extraction method, normalization strategy, and analytical platform. Time of day, diet, and physiological state may also matter. These factors make direct comparisons across studies difficult.
NAD+ is generally more stable when stored dry and cold, and it can degrade in aqueous solutions over time. Heat, light, and alkaline conditions can accelerate loss. Laboratory protocols therefore often recommend frozen storage and protection from light.
NAD+ is the oxidized form, while NADH is the reduced form carrying an additional hydride equivalent. The pair participates in reversible electron transfer reactions. Their ratio helps indicate the redox state of a compartment.